Canadian Stocks Fall, led by Valeant Pharmaceuticals

The TSX starts the week in the red.

| More on:
The Motley Fool

Unlike our neighbors to the south, the S&P/TSX Composite Index (INDEX:^GSPTSE) was unable to muster enough of a late-day rally to finish the day in the green.  The Canadian market closed down 40.6 points or -0.3% to start off this first week of June.  Sort of appropriate given that’s about what the outdoor temperature did today as well, at least in this part of the country.

Valeant Pharmaceuticals (TSX:VRX) was the biggest drag on the Canadian index today, as the stock fell 4.9%, seemingly on no news.  Valeant has telegraphed that it’s going to issue equity to finance its recent purchase of Bausch + Lomb, and therefore, today’s sell-off could be a result of institutions shorting the stock, hoping to buy it back at a cheaper price through the equity offering.

Also falling on no apparent news was Potash (TSX:POT).  The stock was down 2.3% and was the second largest contributor to today’s decline.

On the back of a downgrade by Goldman Sachs, Canadian Natural Resources (TSX:CNQ) and its 2.2% decline was another negative contributor.  Goldman took their target from $33 to $28 due to its concerns over the price of oil that CNQ is likely to receive over the 2014/15 periods.  B.C.’s decision to decline Enbridge’s Nothern Gateway pipeline was a potential catalyst for Goldman’s move.

Finally, CP Rail’s (TSX:CP) stock fell 1.7% on Monday.  This move down was potentially the result of a container train derailment over the weekend in NW Ontario.  The stock is down even more in after-hours trade as well after Pershing Square, Bill Ackman’s firm, has disclosed its intent to sell up to 7 million of the CP shares that it owns.  CP represents 26% of Pershing Square’s combined assets and they’d like to trim this exposure.

Foolish Takeaway

Once again resource oriented stocks played a significant role in today’s market performance.  Because of their heavy-weights in the TSX, these stocks can be lethal for investors that think they are protected with an index fund or ETF linked to the S&P/TSX Composite Index.

We have prepared a Special FREE Report that will clue you into the perils of investing in this kind of product and suggests an easy to implement alternative strategy.  It’s called “5 Stocks That Should Replace Your Canadian Index Fund” and you can receive a copy at no charge – just by clicking here.

Follow us on Twitter and Facebook for the latest in Foolish investing.

Fool contributor Iain Butler is short $40 July 2013 put options on Potash and long Potash shares.  The Motley Fool doesn’t own shares in any of the companies mentioned.   

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

More on Investing

Investing

3 Stocks to Buy and Hold for Total Returns

For investors seeking excellent total returns over the long haul, here are three Canadian stocks to buy before the market…

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Investing

3 Defensive Stocks That Cautious Investors Can Feel Confident Buying

Consider buying Fortis (TSX:FTS) and other defensive dividend stocks in 2024.

Read more »

healthcare pharma
Stocks for Beginners

2 Healthcare Stocks You Can Buy and Hold for the Next Decade

These two healthcare stocks are showing strong signs of growth for the next decade and are already improving by leaps…

Read more »

analyze data
Tech Stocks

If You’d Invested $500 in Nuvei Stock in 2020, This Is How Much You Would Have Today

Nuvei (TSX:NVEI) stock has seen its shares climb to triple digits and fall below IPO prices. So, what now for…

Read more »

Is Nvidia stock a buy?
Tech Stocks

Is Nvidia Stock a Buy After Its Huge Post-Earnings Surge?

Nvidia (Nasdaq:NVDA) stock jumped after the company’s phenomenal fourth-quarter earnings report, and everyone’s talking about a booming future for AI.…

Read more »

Man data analyze
Dividend Stocks

1 Recession-Resistant Stock to Buy and Hold Forever

Brookfield Renewable is a recession-resistant high dividend stock trading at a cheap valuation in 2024.

Read more »

Technology
Bank Stocks

Is TD Bank Stock a Buy Now After Solid Earnings?

TD deserves to be on your radar today.

Read more »

potted green plant grows up in arrow shape
Dividend Stocks

3 Hypergrowth Stocks to Buy in 2024 and Beyond

There are stocks growing, and there are stocks hitting all-time highs. These are three that I would therefore consider on…

Read more »